CEO Dr. Shaun Passley Consolidates 86.5% Voting Control of ZenaTech Through Equity Grants and Asset Acquisition
ZENA sits 20% above its 52-week low of $1.82.
Summary
ZenaTech CEO Dr. Shaun Passley has consolidated 86.5% of the company's voting power through equity grants and an asset acquisition, following shareholder approval in January 2026.
Key Events · Ownership and Investor Activity · ZENA
-
CEO Consolidates Voting Control
Dr. Shaun Passley, CEO of ZenaTech, Inc., now controls 86.5% of the company's total voting power, significantly centralizing corporate governance.
-
Control Achieved Through Equity Grants and Asset Acquisition
The consolidated control stems from equity grants to Dr. Passley under a new CEO employment agreement and shares issued for the acquisition of assets from Epazz, Inc., both approved by shareholders on January 30, 2026.
-
Complex Ownership Structure Detailed
Dr. Passley's control is exercised through direct holdings, as well as through Epazz Inc. (66.4% voting power) and Ameritek Ventures, Inc. (2.5% voting power), both of which he controls.
-
Super-Voting and Convertible Shares Utilized
The voting power includes preferred shares convertible into common shares at a 3:1 ratio and super-voting shares, each carrying 1,000 votes, contributing to the high concentration of control.
Analysis · ZENA · Technology
This Schedule 13D/A filing reveals a significant consolidation of voting power by CEO Dr. Shaun Passley, who now controls 86.5% of ZenaTech, Inc.'s total votes. This substantial level of control, achieved through a combination of direct holdings, convertible preferred shares, and super-voting shares, centralizes decision-making authority. While the underlying share issuances were approved by shareholders in January 2026, this amendment provides critical detail on the extent and mechanisms of the CEO's influence. Investors should note the implications for corporate governance, as Dr. Passley's near-absolute control means he can largely dictate the company's strategic direction and major corporate actions. This filing provides important context for understanding the company's leadership structure.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 42% of the 419 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ZENA was trading at $2.19 on NASDAQ in the Technology sector, with a market capitalization of approximately $104.3M. The 52-week trading range was $1.82 to $7.11. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.